GGrantIndex
Sort

46,585 grants matching heart failure

The Effects of Cannabinoids and Route of Cannabis Administration on Subclinical Cardiovascular Disease Risk

$732,898
Denise Christina Vidot · University Of Miami Coral Gables · R01 · FY2022 · HL

Chronic Kidney Disease Prognosis Consortium

$732,893
Josef Coresh · Johns Hopkins University · R01 · FY2019 · DK

MAE-WEST SCORE Project 2 Clinical

$732,860
C. Noel Bairey Merz · Cedars-Sinai Medical Center · U54 · FY2021 · AG

Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension

$732,819
Vinicio A De Jesus Perez · Stanford University · R01 · FY2022 · HL

Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP)

$732,810
Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Cardiac Myocyte Protein Partners in Heart Function

$732,781
Robert Scott Ross · University Of California, San Diego · R01 · FY2022 · HL

Uncovering The Mechanogenomic Basis For Cardiac Plasticity

$732,762
Jennifer Michelle Davis · University Of Washington · R01 · FY2024 · HL

Molecular control of cardiac regenerative potential

$732,709
Guo Huang · University Of California, San Francisco · R01 · FY2024 · HL

Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap

$732,624
Gary K Owens · University Of Virginia · R01 · FY2024 · HL

Midlife cardiovascular stress physiology and preclinical cerebrovascular disease

$732,593
Peter J Gianaros · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL

Image-guided Intravascular Robotic System for Mitral Valve Repair and Implants

$732,577
Jaydev P. Desai · Georgia Institute Of Technology · R01 · FY2020 · HL

Promoting algorithmic equity in in-hospital mortality prediction

$732,488
Rachel Kohn · University Of Pennsylvania · R01 · FY2025 · HL

Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics

$732,468
Ruth Dubin · Ut Southwestern Medical Center · R01 · FY2024 · HL

Vitamin B12 status, cognitive decline and incident dementia

$732,427
Paul F Jacques · Tufts University Boston · R01 · FY2022 · AG

Genomics of myocardial transcription factors in cardiac remodeling

$732,381
Thomas P Cappola · University Of Pennsylvania · R01 · FY2007 · HL

Predictors of hemorrhage among patients on direct acting oral anticoagulants

$732,370
Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2021 · HL

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

$732,265
Miguel Valderrabano · Methodist Hospital Research Institute · R01 · FY2016 · HL

Functional Genomics of Cardiac Sodium Channel Variants

$732,233
Dan M Roden · Vanderbilt University Medical Center · R01 · FY2020 · HL

Improving cardiac rehabilitation outcomes with evidence-based obesity treatment.

$732,215
Tina E Brinkley · Wake Forest University Health Sciences · R56 · FY2017 · HL

Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients

$732,181
Robert T Tranquillo · University Of Minnesota · R01 · FY2020 · HL

Protein therapy to treat virus induced cardiopulmonary injury

$732,174
Jianjie Ma · University Of Virginia · R01 · FY2022 · HL

Improving access to renal transplantation for Underserved Black Communities

$732,172
Daniela P Ladner · Northwestern University At Chicago · U01 · FY2024 · DK

Childhood Hypertension and Obesity: Diagnosis, Care, and Costs

$732,141
Patrick J O'Connor · Healthpartners Institute · R01 · FY2010 · HL

Ambulatory Assist Lung for Children

$732,102
William J Federspiel · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL

2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$732,050
Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2024 · HL